Specialty code 183500000X · Vacaville, CA
NPI
1730166638
Since 2005
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Quality Dr, Kaiser Pharmacy Department
Vacaville, CA, 95688
Phone (707) 624-3565
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$363K
1,983 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer C Ho prescribed most often to Medicare patients was Atorvastatin Calcium, with 205 prescriptions and refills. In total Jennifer C Ho wrote 1,983 Medicare prescriptions that cost $363K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 205 | 683 | 81 | $2,569 |
| Metformin Hcl Er Metformin Hcl | 191 | 625 | 81 | $1,848 |
| Metformin Hcl Generic | 168 | 558 | 58 | $2,263 |
| Ozempic Semaglutide | 167 | 171 | 33 | $124K |
| Humulin N Insulin Nph Human Isophane | 156 | 492 | 62 | $38K |
| Glipizide Generic | 125 | 408 | 46 | $1,556 |
| Glipizide Er Glipizide | 82 | 271 | 35 | $2,494 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 81 | 261 | 36 | $2,096 |
| Insulin Glargine-Yfgn Generic | 79 | 228 | 43 | $14K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 61 | 175 | 25 | $1,213 |
| Humulin R Insulin Regular, Human | 59 | 178 | 25 | $11K |
| Jardiance Empagliflozin | 57 | 188 | 27 | $31K |
| Victoza 2-Pak Liraglutide | 55 | 55 | 13 | $35K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 50 | 162 | 23 | $1,358 |
| Liraglutide Generic | 47 | 47 | 15 | $34K |
Brand drugs: 747 claims; generic drugs: 1,006 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jennifer C Ho were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.